nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Sulfasalazine—ankylosing spondylitis	0.176	0.526	CbGbCtD
Cladribine—ABCG2—Dexamethasone—ankylosing spondylitis	0.0877	0.263	CbGbCtD
Cladribine—ABCG2—Methotrexate—ankylosing spondylitis	0.0705	0.211	CbGbCtD
Cladribine—PNP—Balsalazide—Sulfasalazine—ankylosing spondylitis	0.0053	0.188	CbGdCrCtD
Cladribine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000927	0.00145	CcSEcCtD
Cladribine—Oedema—Prednisolone—ankylosing spondylitis	0.000922	0.00145	CcSEcCtD
Cladribine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000921	0.00144	CcSEcCtD
Cladribine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000916	0.00143	CcSEcCtD
Cladribine—Cough—Triamcinolone—ankylosing spondylitis	0.000907	0.00142	CcSEcCtD
Cladribine—Tachycardia—Prednisolone—ankylosing spondylitis	0.0009	0.00141	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000892	0.0014	CcSEcCtD
Cladribine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000885	0.00139	CcSEcCtD
Cladribine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000883	0.00138	CcSEcCtD
Cladribine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000883	0.00138	CcSEcCtD
Cladribine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000883	0.00138	CcSEcCtD
Cladribine—Eye disorder—Prednisone—ankylosing spondylitis	0.000882	0.00138	CcSEcCtD
Cladribine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00088	0.00138	CcSEcCtD
Cladribine—Infestation—Methotrexate—ankylosing spondylitis	0.000878	0.00138	CcSEcCtD
Cladribine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000878	0.00138	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000877	0.00137	CcSEcCtD
Cladribine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000875	0.00137	CcSEcCtD
Cladribine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000875	0.00137	CcSEcCtD
Cladribine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000874	0.00137	CcSEcCtD
Cladribine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000872	0.00137	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000871	0.00136	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	0.000868	0.0309	CbGdCrCtD
Cladribine—Renal failure—Methotrexate—ankylosing spondylitis	0.000863	0.00135	CcSEcCtD
Cladribine—PNP—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.000857	0.0305	CbGdCrCtD
Cladribine—Angiopathy—Prednisone—ankylosing spondylitis	0.000856	0.00134	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	0.000855	0.0304	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Betamethasone—ankylosing spondylitis	0.000855	0.0304	CbGdCrCtD
Cladribine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000854	0.00134	CcSEcCtD
Cladribine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000853	0.00134	CcSEcCtD
Cladribine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000852	0.00134	CcSEcCtD
Cladribine—Malaise—Betamethasone—ankylosing spondylitis	0.00085	0.00133	CcSEcCtD
Cladribine—Malaise—Dexamethasone—ankylosing spondylitis	0.00085	0.00133	CcSEcCtD
Cladribine—Oedema—Triamcinolone—ankylosing spondylitis	0.000848	0.00133	CcSEcCtD
Cladribine—PNP—Flunisolide—Dexamethasone—ankylosing spondylitis	0.000843	0.03	CbGdCrCtD
Cladribine—PNP—Flunisolide—Betamethasone—ankylosing spondylitis	0.000843	0.03	CbGdCrCtD
Cladribine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000843	0.00132	CcSEcCtD
Cladribine—Infection—Triamcinolone—ankylosing spondylitis	0.000843	0.00132	CcSEcCtD
Cladribine—Infection—Methylprednisolone—ankylosing spondylitis	0.000841	0.00132	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	0.000835	0.0297	CbGdCrCtD
Cladribine—Insomnia—Prednisolone—ankylosing spondylitis	0.000834	0.00131	CcSEcCtD
Cladribine—Alopecia—Prednisone—ankylosing spondylitis	0.000834	0.00131	CcSEcCtD
Cladribine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000831	0.0013	CcSEcCtD
Cladribine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00083	0.0013	CcSEcCtD
Cladribine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000828	0.0013	CcSEcCtD
Cladribine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000828	0.0013	CcSEcCtD
Cladribine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000828	0.0013	CcSEcCtD
Cladribine—PNP—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000827	0.0294	CbGdCrCtD
Cladribine—Mental disorder—Prednisone—ankylosing spondylitis	0.000827	0.0013	CcSEcCtD
Cladribine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000826	0.00129	CcSEcCtD
Cladribine—PNP—Flunisolide—Triamcinolone—ankylosing spondylitis	0.000824	0.0293	CbGdCrCtD
Cladribine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000822	0.00129	CcSEcCtD
Cladribine—Malnutrition—Prednisone—ankylosing spondylitis	0.000821	0.00129	CcSEcCtD
Cladribine—Erythema—Prednisone—ankylosing spondylitis	0.000821	0.00129	CcSEcCtD
Cladribine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00082	0.00129	CcSEcCtD
Cladribine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000818	0.00128	CcSEcCtD
Cladribine—PNP—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000814	0.029	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000814	0.029	CbGdCrCtD
Cladribine—Myalgia—Betamethasone—ankylosing spondylitis	0.000803	0.00126	CcSEcCtD
Cladribine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000803	0.00126	CcSEcCtD
Cladribine—Anxiety—Dexamethasone—ankylosing spondylitis	0.0008	0.00125	CcSEcCtD
Cladribine—Anxiety—Betamethasone—ankylosing spondylitis	0.0008	0.00125	CcSEcCtD
Cladribine—PNP—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000795	0.0283	CbGdCrCtD
Cladribine—Discomfort—Betamethasone—ankylosing spondylitis	0.000793	0.00124	CcSEcCtD
Cladribine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000793	0.00124	CcSEcCtD
Cladribine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000792	0.00124	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Prednisone—ankylosing spondylitis	0.000792	0.0282	CbGdCrCtD
Cladribine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000791	0.00124	CcSEcCtD
Cladribine—Pain—Prednisolone—ankylosing spondylitis	0.000789	0.00124	CcSEcCtD
Cladribine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000788	0.00124	CcSEcCtD
Cladribine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000783	0.00123	CcSEcCtD
Cladribine—PNP—Flunisolide—Prednisone—ankylosing spondylitis	0.000782	0.0278	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Methylprednisolone—ankylosing spondylitis	0.000779	0.0277	CbGdCrCtD
Cladribine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000779	0.00122	CcSEcCtD
Cladribine—PNP—Clobetasol propionate—Prednisolone—ankylosing spondylitis	0.000773	0.0275	CbGdCrCtD
Cladribine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000773	0.00121	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000773	0.00121	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000771	0.00121	CcSEcCtD
Cladribine—Oedema—Betamethasone—ankylosing spondylitis	0.00077	0.00121	CcSEcCtD
Cladribine—Oedema—Dexamethasone—ankylosing spondylitis	0.00077	0.00121	CcSEcCtD
Cladribine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000767	0.0012	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Betamethasone—ankylosing spondylitis	0.000767	0.0273	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Dexamethasone—ankylosing spondylitis	0.000767	0.0273	CbGdCrCtD
Cladribine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000765	0.0012	CcSEcCtD
Cladribine—Infection—Dexamethasone—ankylosing spondylitis	0.000765	0.0012	CcSEcCtD
Cladribine—Infection—Betamethasone—ankylosing spondylitis	0.000765	0.0012	CcSEcCtD
Cladribine—PNP—Flunisolide—Prednisolone—ankylosing spondylitis	0.000763	0.0272	CbGdCrCtD
Cladribine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000762	0.00119	CcSEcCtD
Cladribine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000762	0.00119	CcSEcCtD
Cladribine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00076	0.00119	CcSEcCtD
Cladribine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00076	0.00119	CcSEcCtD
Cladribine—Anaemia—Prednisone—ankylosing spondylitis	0.000759	0.00119	CcSEcCtD
Cladribine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000756	0.00119	CcSEcCtD
Cladribine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000755	0.00118	CcSEcCtD
Cladribine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000755	0.00118	CcSEcCtD
Cladribine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000754	0.00118	CcSEcCtD
Cladribine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000754	0.00118	CcSEcCtD
Cladribine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000751	0.00118	CcSEcCtD
Cladribine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000751	0.00118	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Triamcinolone—ankylosing spondylitis	0.00075	0.0267	CbGdCrCtD
Cladribine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000745	0.00117	CcSEcCtD
Cladribine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000744	0.00117	CcSEcCtD
Cladribine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000744	0.00117	CcSEcCtD
Cladribine—Malaise—Prednisone—ankylosing spondylitis	0.000741	0.00116	CcSEcCtD
Cladribine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000737	0.00115	CcSEcCtD
Cladribine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000734	0.00115	CcSEcCtD
Cladribine—Anorexia—Betamethasone—ankylosing spondylitis	0.000734	0.00115	CcSEcCtD
Cladribine—Urticaria—Prednisolone—ankylosing spondylitis	0.000733	0.00115	CcSEcCtD
Cladribine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000732	0.00115	CcSEcCtD
Cladribine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000731	0.00115	CcSEcCtD
Cladribine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00073	0.00114	CcSEcCtD
Cladribine—Pain—Triamcinolone—ankylosing spondylitis	0.000725	0.00114	CcSEcCtD
Cladribine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000719	0.00113	CcSEcCtD
Cladribine—Hypotension—Betamethasone—ankylosing spondylitis	0.000719	0.00113	CcSEcCtD
Cladribine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000715	0.00112	CcSEcCtD
Cladribine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000712	0.00112	CcSEcCtD
Cladribine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000711	0.00111	CcSEcCtD
Cladribine—Chills—Methotrexate—ankylosing spondylitis	0.000707	0.00111	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000701	0.0011	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000701	0.0011	CcSEcCtD
Cladribine—Myalgia—Prednisone—ankylosing spondylitis	0.000699	0.0011	CcSEcCtD
Cladribine—Arthralgia—Prednisone—ankylosing spondylitis	0.000699	0.0011	CcSEcCtD
Cladribine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000699	0.0011	CcSEcCtD
Cladribine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000697	0.00109	CcSEcCtD
Cladribine—Anxiety—Prednisone—ankylosing spondylitis	0.000697	0.00109	CcSEcCtD
Cladribine—Alopecia—Methotrexate—ankylosing spondylitis	0.000697	0.00109	CcSEcCtD
Cladribine—Insomnia—Betamethasone—ankylosing spondylitis	0.000696	0.00109	CcSEcCtD
Cladribine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000696	0.00109	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000694	0.00109	CcSEcCtD
Cladribine—PNP—Fluocinolone Acetonide—Prednisolone—ankylosing spondylitis	0.000694	0.0247	CbGdCrCtD
Cladribine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000692	0.00108	CcSEcCtD
Cladribine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000691	0.00108	CcSEcCtD
Cladribine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000691	0.00108	CcSEcCtD
Cladribine—Discomfort—Prednisone—ankylosing spondylitis	0.000691	0.00108	CcSEcCtD
Cladribine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000691	0.00108	CcSEcCtD
Cladribine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000686	0.00108	CcSEcCtD
Cladribine—Erythema—Methotrexate—ankylosing spondylitis	0.000686	0.00108	CcSEcCtD
Cladribine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00068	0.00107	CcSEcCtD
Cladribine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000674	0.00106	CcSEcCtD
Cladribine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000672	0.00105	CcSEcCtD
Cladribine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000671	0.00105	CcSEcCtD
Cladribine—Oedema—Prednisone—ankylosing spondylitis	0.00067	0.00105	CcSEcCtD
Cladribine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000669	0.00105	CcSEcCtD
Cladribine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000669	0.00105	CcSEcCtD
Cladribine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000669	0.00105	CcSEcCtD
Cladribine—Infection—Prednisone—ankylosing spondylitis	0.000666	0.00104	CcSEcCtD
Cladribine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000664	0.00104	CcSEcCtD
Cladribine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000664	0.00104	CcSEcCtD
Cladribine—Back pain—Methotrexate—ankylosing spondylitis	0.000664	0.00104	CcSEcCtD
Cladribine—Fatigue—Betamethasone—ankylosing spondylitis	0.000664	0.00104	CcSEcCtD
Cladribine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000664	0.00104	CcSEcCtD
Cladribine—Pain—Betamethasone—ankylosing spondylitis	0.000658	0.00103	CcSEcCtD
Cladribine—Pain—Dexamethasone—ankylosing spondylitis	0.000658	0.00103	CcSEcCtD
Cladribine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000657	0.00103	CcSEcCtD
Cladribine—Tachycardia—Prednisone—ankylosing spondylitis	0.000654	0.00103	CcSEcCtD
Cladribine—Skin disorder—Prednisone—ankylosing spondylitis	0.000651	0.00102	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000648	0.00102	CcSEcCtD
Cladribine—Anorexia—Prednisone—ankylosing spondylitis	0.000639	0.001	CcSEcCtD
Cladribine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000637	0.000998	CcSEcCtD
Cladribine—Anaemia—Methotrexate—ankylosing spondylitis	0.000634	0.000994	CcSEcCtD
Cladribine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000634	0.000994	CcSEcCtD
Cladribine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000634	0.000994	CcSEcCtD
Cladribine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000629	0.000986	CcSEcCtD
Cladribine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000629	0.000986	CcSEcCtD
Cladribine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000625	0.00098	CcSEcCtD
Cladribine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000624	0.000977	CcSEcCtD
Cladribine—Malaise—Methotrexate—ankylosing spondylitis	0.000619	0.00097	CcSEcCtD
Cladribine—Urticaria—Betamethasone—ankylosing spondylitis	0.000611	0.000958	CcSEcCtD
Cladribine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000611	0.000958	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000611	0.000957	CcSEcCtD
Cladribine—Dizziness—Prednisolone—ankylosing spondylitis	0.00061	0.000956	CcSEcCtD
Cladribine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000609	0.000954	CcSEcCtD
Cladribine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000608	0.000954	CcSEcCtD
Cladribine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000608	0.000954	CcSEcCtD
Cladribine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000608	0.000954	CcSEcCtD
Cladribine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000608	0.000954	CcSEcCtD
Cladribine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000607	0.000952	CcSEcCtD
Cladribine—Insomnia—Prednisone—ankylosing spondylitis	0.000606	0.00095	CcSEcCtD
Cladribine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000602	0.000943	CcSEcCtD
Cladribine—Pruritus—Triamcinolone—ankylosing spondylitis	0.0006	0.000941	CcSEcCtD
Cladribine—PNP—Danazol—Prednisone—ankylosing spondylitis	0.000599	0.0213	CbGdCrCtD
Cladribine—Cough—Methotrexate—ankylosing spondylitis	0.000599	0.000939	CcSEcCtD
Cladribine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000599	0.000939	CcSEcCtD
Cladribine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000584	0.000916	CcSEcCtD
Cladribine—Myalgia—Methotrexate—ankylosing spondylitis	0.000584	0.000916	CcSEcCtD
Cladribine—Chest pain—Methotrexate—ankylosing spondylitis	0.000584	0.000916	CcSEcCtD
Cladribine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000583	0.000913	CcSEcCtD
Cladribine—Rash—Prednisolone—ankylosing spondylitis	0.000582	0.000912	CcSEcCtD
Cladribine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000581	0.000911	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00058	0.00091	CcSEcCtD
Cladribine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000579	0.000908	CcSEcCtD
Cladribine—Fatigue—Prednisone—ankylosing spondylitis	0.000578	0.000906	CcSEcCtD
Cladribine—Headache—Prednisolone—ankylosing spondylitis	0.000578	0.000906	CcSEcCtD
Cladribine—Discomfort—Methotrexate—ankylosing spondylitis	0.000577	0.000905	CcSEcCtD
Cladribine—Constipation—Prednisone—ankylosing spondylitis	0.000573	0.000898	CcSEcCtD
Cladribine—Confusional state—Methotrexate—ankylosing spondylitis	0.000565	0.000885	CcSEcCtD
Cladribine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000561	0.000879	CcSEcCtD
Cladribine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00056	0.000877	CcSEcCtD
Cladribine—Infection—Methotrexate—ankylosing spondylitis	0.000557	0.000872	CcSEcCtD
Cladribine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000552	0.000866	CcSEcCtD
Cladribine—Asthenia—Betamethasone—ankylosing spondylitis	0.000552	0.000865	CcSEcCtD
Cladribine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000552	0.000865	CcSEcCtD
Cladribine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000549	0.000861	CcSEcCtD
Cladribine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000548	0.00086	CcSEcCtD
Cladribine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000548	0.000859	CcSEcCtD
Cladribine—Nausea—Prednisolone—ankylosing spondylitis	0.000548	0.000859	CcSEcCtD
Cladribine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000545	0.000853	CcSEcCtD
Cladribine—Pruritus—Betamethasone—ankylosing spondylitis	0.000545	0.000853	CcSEcCtD
Cladribine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000544	0.000853	CcSEcCtD
Cladribine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000542	0.000849	CcSEcCtD
Cladribine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000539	0.000845	CcSEcCtD
Cladribine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000538	0.000843	CcSEcCtD
Cladribine—Rash—Triamcinolone—ankylosing spondylitis	0.000535	0.000838	CcSEcCtD
Cladribine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000534	0.000837	CcSEcCtD
Cladribine—Anorexia—Methotrexate—ankylosing spondylitis	0.000534	0.000837	CcSEcCtD
Cladribine—Rash—Methylprednisolone—ankylosing spondylitis	0.000534	0.000836	CcSEcCtD
Cladribine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000533	0.000836	CcSEcCtD
Cladribine—Urticaria—Prednisone—ankylosing spondylitis	0.000532	0.000835	CcSEcCtD
Cladribine—Headache—Triamcinolone—ankylosing spondylitis	0.000531	0.000833	CcSEcCtD
Cladribine—Headache—Methylprednisolone—ankylosing spondylitis	0.00053	0.000831	CcSEcCtD
Cladribine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00053	0.00083	CcSEcCtD
Cladribine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00053	0.00083	CcSEcCtD
Cladribine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000527	0.000825	CcSEcCtD
Cladribine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000527	0.000825	CcSEcCtD
Cladribine—Hypotension—Methotrexate—ankylosing spondylitis	0.000523	0.00082	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00051	0.0008	CcSEcCtD
Cladribine—Dizziness—Betamethasone—ankylosing spondylitis	0.000509	0.000798	CcSEcCtD
Cladribine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000509	0.000798	CcSEcCtD
Cladribine—Insomnia—Methotrexate—ankylosing spondylitis	0.000507	0.000794	CcSEcCtD
Cladribine—Nausea—Triamcinolone—ankylosing spondylitis	0.000504	0.00079	CcSEcCtD
Cladribine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000503	0.000788	CcSEcCtD
Cladribine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000503	0.000788	CcSEcCtD
Cladribine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000499	0.000783	CcSEcCtD
Cladribine—Somnolence—Methotrexate—ankylosing spondylitis	0.000498	0.000781	CcSEcCtD
Cladribine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000494	0.000774	CcSEcCtD
Cladribine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000489	0.000767	CcSEcCtD
Cladribine—Vomiting—Betamethasone—ankylosing spondylitis	0.000489	0.000767	CcSEcCtD
Cladribine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000487	0.000763	CcSEcCtD
Cladribine—Rash—Betamethasone—ankylosing spondylitis	0.000485	0.000761	CcSEcCtD
Cladribine—Rash—Dexamethasone—ankylosing spondylitis	0.000485	0.000761	CcSEcCtD
Cladribine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000485	0.00076	CcSEcCtD
Cladribine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000485	0.00076	CcSEcCtD
Cladribine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000484	0.000758	CcSEcCtD
Cladribine—Fatigue—Methotrexate—ankylosing spondylitis	0.000483	0.000757	CcSEcCtD
Cladribine—Headache—Dexamethasone—ankylosing spondylitis	0.000482	0.000756	CcSEcCtD
Cladribine—Headache—Betamethasone—ankylosing spondylitis	0.000482	0.000756	CcSEcCtD
Cladribine—Asthenia—Prednisone—ankylosing spondylitis	0.000481	0.000754	CcSEcCtD
Cladribine—Pain—Methotrexate—ankylosing spondylitis	0.000479	0.000751	CcSEcCtD
Cladribine—Pruritus—Prednisone—ankylosing spondylitis	0.000474	0.000743	CcSEcCtD
Cladribine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00047	0.0167	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.000463	0.0165	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.000463	0.0165	CbGdCrCtD
Cladribine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000462	0.000723	CcSEcCtD
Cladribine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000459	0.000719	CcSEcCtD
Cladribine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000458	0.000718	CcSEcCtD
Cladribine—Nausea—Betamethasone—ankylosing spondylitis	0.000457	0.000717	CcSEcCtD
Cladribine—Nausea—Dexamethasone—ankylosing spondylitis	0.000457	0.000717	CcSEcCtD
Cladribine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000457	0.0162	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.000452	0.0161	CbGdCrCtD
Cladribine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.000449	0.016	CbGdCrCtD
Cladribine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000449	0.016	CbGdCrCtD
Cladribine—Urticaria—Methotrexate—ankylosing spondylitis	0.000445	0.000697	CcSEcCtD
Cladribine—Dizziness—Prednisone—ankylosing spondylitis	0.000443	0.000695	CcSEcCtD
Cladribine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000443	0.000694	CcSEcCtD
Cladribine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000443	0.000694	CcSEcCtD
Cladribine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000439	0.0156	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.000429	0.0153	CbGdCrCtD
Cladribine—Vomiting—Prednisone—ankylosing spondylitis	0.000426	0.000668	CcSEcCtD
Cladribine—Rash—Prednisone—ankylosing spondylitis	0.000423	0.000662	CcSEcCtD
Cladribine—Dermatitis—Prednisone—ankylosing spondylitis	0.000422	0.000662	CcSEcCtD
Cladribine—Headache—Prednisone—ankylosing spondylitis	0.00042	0.000658	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.000419	0.0149	CbGdCrCtD
Cladribine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.000417	0.0148	CbGdCrCtD
Cladribine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000413	0.000647	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.000407	0.0145	CbGdCrCtD
Cladribine—Asthenia—Methotrexate—ankylosing spondylitis	0.000402	0.00063	CcSEcCtD
Cladribine—Nausea—Prednisone—ankylosing spondylitis	0.000398	0.000624	CcSEcCtD
Cladribine—Pruritus—Methotrexate—ankylosing spondylitis	0.000396	0.000621	CcSEcCtD
Cladribine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000383	0.000601	CcSEcCtD
Cladribine—Dizziness—Methotrexate—ankylosing spondylitis	0.00037	0.000581	CcSEcCtD
Cladribine—Vomiting—Methotrexate—ankylosing spondylitis	0.000356	0.000558	CcSEcCtD
Cladribine—Rash—Methotrexate—ankylosing spondylitis	0.000353	0.000554	CcSEcCtD
Cladribine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000353	0.000553	CcSEcCtD
Cladribine—Headache—Methotrexate—ankylosing spondylitis	0.000351	0.00055	CcSEcCtD
Cladribine—Nausea—Methotrexate—ankylosing spondylitis	0.000333	0.000521	CcSEcCtD
